Use of FAAH Inhibitors for Treating Parkinson's Disease and Restless Legs Syndrome
The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), the use of FAAH inhibitors for the manufacture of medicaments for use in the tre...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
13.06.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinson's disease (PD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), the use of FAAH inhibitors for the manufacture of medicaments for use in the treatment of PD, RLS and PLMD, as well as pharmaceutically acceptable compositions comprising FAAH inhibitors for use in the treatment of PD, RLS and PLMD. |
---|---|
Bibliography: | Application Number: US201113520644 |